MENU
+Compare
ARKAY
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$76.44
Change
+$0.21 (+0.28%)
Capitalization
8.05B

ARKAY Arkema Forecast, Technical & Fundamental Analysis

Arkema SA is a French chemical company formerly known for its large presence in the acrylics market... Show more

ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ARKAY with price predictions
Jul 25, 2025

ARKAY's RSI Oscillator leaves overbought zone

The 10-day RSI Indicator for ARKAY moved out of overbought territory on July 03, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKAY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARKAY broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on ARKAY as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ARKAY just turned positive on July 24, 2025. Looking at past instances where ARKAY's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

The 50-day moving average for ARKAY moved above the 200-day moving average on July 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKAY advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 235 cases where ARKAY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.001) is normal, around the industry mean (3.653). P/E Ratio (14.286) is within average values for comparable stocks, (34.612). Projected Growth (PEG Ratio) (0.873) is also within normal values, averaging (6.312). Dividend Yield (0.035) settles around the average of (0.037) among similar stocks. P/S Ratio (0.686) is also within normal values, averaging (97.810).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ARKAY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARKAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.

View a ticker or compare two or three
ARKAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ARKAY is expected to report earnings to rise 46.62% to $2.17 per share on July 31

Arkema ARKAY Stock Earnings Reports
Q2'25
Est.
$2.17
Q1'25
Missed
by $0.26
Q4'24
Missed
by $0.48
Q3'24
Missed
by $0.14
Q2'24
Beat
by $0.34
The last earnings report on May 07 showed earnings per share of $1.48, missing the estimate of $1.74. With 9.93K shares outstanding, the current market capitalization sits at 8.05B.
A.I.Advisor
published Dividends

ARKAY paid dividends on June 12, 2025

Arkema ARKAY Stock Dividends
А dividend of $8.13 per share was paid with a record date of June 12, 2025, and an ex-dividend date of May 22, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry ChemicalsSpecialty

Profile
Fundamentals
Details
Industry
N/A
Address
420 rue d’Estienne d’Orves
Phone
+33 149008080
Employees
21116
Web
https://www.arkema.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PNOV40.180.12
+0.30%
Innovator US Equity Power Buffer ETF Nov
HEAL10.620.01
+0.13%
Global X HealthTech ETF
VXZ57.720.03
+0.05%
iPath® B S&P 500® VIX Md-Trm Futs™ ETN
HEEM30.97-0.02
-0.05%
iShares Currency Hedged MSCI Em Mkts ETF
VSS137.11-0.13
-0.09%
Vanguard FTSE All-Wld ex-US SmCp ETF

ARKAY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARKAY has been loosely correlated with BASFY. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ARKAY jumps, then BASFY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARKAY
1D Price
Change %
ARKAY100%
+0.28%
BASFY - ARKAY
63%
Loosely correlated
+0.52%
AKZOY - ARKAY
58%
Loosely correlated
+1.00%
SXYAY - ARKAY
48%
Loosely correlated
+1.55%
JMPLY - ARKAY
46%
Loosely correlated
N/A
BNTGY - ARKAY
41%
Loosely correlated
+0.90%
More